InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.970
-0.160 (-7.51%)
At close: May 5, 2026, 4:00 PM EDT
1.951
-0.019 (-0.98%)
After-hours: May 5, 2026, 7:36 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $142.42 million as of May 5, 2026. Its market cap has increased by 126.42% in one year.
Market Cap
142.42M
Enterprise Value
88.92M
1-Year Change
126.42%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $142.42M, a decrease of -59.41%. That is a compound annual growth rate of -10.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 154.00M | 125.15% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 156.30M |
| Spruce Biosciences | 154.79M |
| Molecular Partners AG | 153.58M |
| Tenaya Therapeutics | 153.16M |
| Kazia Therapeutics | 153.01M |
| Alps Group | 151.41M |
| Galectin Therapeutics | 149.43M |
| Black Diamond Therapeutics | 148.95M |